
Stem Cell Milestone: Japan Approves World's First iPSC-Derived Medical Products
Japan has granted the world's first regulatory approval for a medical product derived from induced pluripotent stem cells (iPSCs), a technology that won the Nobel Prize in 2012. This milestone enables the mass production of standardized 'off-the-shelf' cell therapies, starting with cancer treatments. Analysts expect this move to trigger a global surge in regenerative medicine investment and set new regulatory standards for the US and Europe.
